Search Results for "post-COVID landscape"

Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Sep 9^th • 5 mins read

Tom Caravela

MSL Evolution: New Trends and Titles That May Emerge

Apr 5^th • 1 min read

Charles Oo, Barbara Ameer

Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic

Apr 29^th • 2 mins read

Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Dec 1^st • 4 mins read

Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD

Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives

Aug 7^th • 10 mins read

Eric Q. Konnick

The regulatory landscape of precision oncology laboratory medicine in the United States - Perspective on the past 5 years and considerations for future regulation

May 22^nd • 8 mins read

Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Apr 29^th • 8 mins read

Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD

Outcome measures for oncology alternative payment models: practical considerations and recommendations

Dec 1^st • 10 mins read

Envision Pharma Group

Medical affairs: The power behind redefining commercialization

Aug 2^nd • 3 mins read

E Dawn Flick, Howard R Terebelo, Susan Fish, Amani Kitali, Vrinda Mahajan, Melissa Nifenecker, Kristen Sullivan, Paul Thaler, Sarah Ussery, David L Grinblatt

The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research

Jun 7^th • 8 mins read

Peter Varnai, Anoushka Davé, Kristine Farla, Anke Nooijen, Liana Petrosova

The Evidence REVEAL Study: Exploring the Use of Real-World Evidence and Complex Clinical Trial Design by the European Pharmaceutical Industry

Nov 20^th • 10 mins read

Sean P Martin, Xin Wei Wang

The evolving landscape of precision medicine in primary liver cancer

Mar 29^th • 3 mins read

Nicole M. Kuderer and Gary H. Lyman

Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety

Jun 20^th • 3 mins read